Lifecore Biomedical Inc
NASDAQ:LFCR
Gross Margin
Lifecore Biomedical Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
242.2m USD |
35%
|
|
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY |
34%
|
|
| CH |
|
Nestle SA
SIX:NESN
|
232.2B CHF |
47%
|
|
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
85.8B USD |
39%
|
|
| FR |
|
Danone SA
PAR:BN
|
46.3B EUR |
50%
|
|
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
41.8B Zac |
28%
|
|
| US |
|
Kraft Heinz Co
NASDAQ:KHC
|
36.6B USD |
35%
|
|
| US |
|
Hershey Co
NYSE:HSY
|
34.5B USD |
47%
|
|
| US |
|
General Mills Inc
NYSE:GIS
|
33.7B USD |
35%
|
|
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
230.6B CNY |
35%
|
|
| ZA |
A
|
Avi Ltd
JSE:AVI
|
31.4B Zac |
42%
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Lifecore Biomedical Inc's most recent financial statements, the company has Gross Margin of 34.9%.
You don't have any saved screeners yet